I. de Tejada
Fundacion para la Investigacion y el Desarollo en Andrologìa
Madrid
Spain
Name/email consistency: low
- The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. Saenz de Tejada, I., Angulo, J., Cuevas, P., Fernández, A., Moncada, I., Allona, A., Lledó, E., Körschen, H.G., Niewöhner, U., Haning, H., Pages, E., Bischoff, E. Int. J. Impot. Res. (2001)
- Regulation of pre-synaptic alpha adrenergic activity in the corpus cavernosum. Saenz de Tejada, I., Kim, N.N., Goldstein, I., Traish, A.M. Int. J. Impot. Res. (2000)
- Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence. de Tejada, I.S., Garvey, D.S., Schroeder, J.D., Shelekhin, T., Letts, L.G., Fernández, A., Cuevas, B., Gabancho, S., Martínez, V., Angulo, J., Trocha, M., Marek, P., Cuevas, P., Tam, S.W. J. Pharmacol. Exp. Ther. (1999)